For patients managing chronic conditions like allergies or migraines, the recurring cost of over-the-counter medications and supplements is a quiet, persistent burden. Onfy, a Berlin-based marketplace founded in 2021, bets a B2B2C model can cut those costs. It connects pharmacies and consumers directly to manufacturers [Onfy.de].
The company claims over 70,000 prescription-free health products priced 20 to 60 percent below recommended retail on average. Discounts reach 75 percent sometimes [TechCrunch].
Founder and CEO Iana Liaskovik aims to disintermediate wholesalers. Pharmacies source vitamins, nasal sprays, and skincare directly. Savings pass to consumers. Independents compete with online giants [Onfy.de].
Onfy embeds Banxware financing for pharmacy credit lines [Banxware.com]. This offers two-sided value: cheaper goods and better cash flow.
German patients choose local Apotheke for service or Shop Apotheke and DocMorris for convenience and discounts. Onfy sits between, offering bulk price advantages, partner fulfillment, and compliance.
Path forward unproven. Needs dense pharmacy network and structural prices. Traction is limited to 83,664 items per one site [Medizinfuchs.de]. Banxware integration signals execution beyond listings. Success depends on proving volume for partners and revenue stability.